Citations

Institution: Mayo Clinic Clear

Showing 10 of 108162 citations.

Abstract A27: Redefining the role of Notch in acinar to ductal metaplasia
Halbrook, Christopher J. , Crawford, Howard C.

Cancer Research | October 5, 2015 | Volume: 75 | Issue: 13_Supplement | Pages: A27-A27

10.1158/1538-7445.panca2014-a27 Get It

Abstract The EGFR and Notch signaling pathways have been widely implicated in relation to both chronic pancreatitis and pancreatic ductal adenocarcinoma in humans, however the link between the two pathways has remained obscure. Acinar to ductal metaplasia (ADM,) a phenomenon where acinar cells undergo a morphological change and begin expressing markers normally found only in ductal cells while losing markers typical of acinar cells, has been linked to both the Notch and EGFR signaling pathways. ADM is highly proliferative with the potential to develop into pancreatic intraepithelial neoplasia, a precursor lesion to pancreatic cancer. Recently we and others have shown that genetic ablation of EGFR in the pancreas effectively prevents acinar to ductal metaplasia in cerulein model of pancreatitis in mice, and prevents tumorigenesis driven by oncogenic Kras. Additionally, we have found that acinar cells harvested from EGFRf/f;Ptf1aCre/+ mice (EKO) mice are resistant to ADM in vitro upon cerulein treatment, or by the expression of oncogenic Kras. Activation of EGFR by treatment of WT collagen embedded acinar cell explants with the EGFR ligand TGF-α has previously been shown to induce ADM in a manner requiring Notch pathway activation. Furthermore, it has also been demonstrated that expression of Notch2 intracellular domain (N2ICD) is sufficient to induce ADM in WT acinar cells. To directly investigate the relationship of the EGFR, Kras, and Notch signaling pathways in ADM, we examined the effect of Notch signaling in acinar cells harvested from EKO mice. Interestingly, these acinar cells fail to transdifferentiate in vitro upon transduction of N2ICD in 3D culture; however the transdifferentiation event can be rescued by co-expression of oncogenic Kras with N2ICD in acinar cells lacking EGFR. These results indicate that EGFR is important in Notch induced ADM, however there are other pathways that possibly can be utilized by acinar cells expressing oncogenic Kras to drive ADM. Citation Format: Christopher J. Halbrook, Howard C. Crawford. Redefining the role of Notch in acinar to ductal metaplasia. [abstract]. In: Proceedings of the AACR Special Conference on Pancreatic Cancer: Innovations in Research and Treatment; May 18-21, 2014; New Orleans, LA. Philadelphia (PA): AACR; Cancer Res 2015;75(13 Suppl):Abstract nr A27.
Abstract A04: PI3K regulation of RAC1 is required for Kras-induced pancreatic tumorigenesis
Takeuchi, Kenneth K., Wu, Claire , Halbrook, Christopher J. , Carpenter, Eileen S. , Lin, Richard Z. , Crawford, Howard C.

Cancer Research | October 5, 2015 | Volume: 75 | Issue: 13_Supplement | Pages: A04-A04

10.1158/1538-7445.panca2014-a04 Get It

Abstract Nearly all pancreatic ductal adenocarcinomas are caused by oncogenic mutations in the KRAS gene. Pharmacological inhibition of mutant KRAS has thus far been unsuccessful in the clinical setting, precipitating a need to understand the pathways downstream of KRAS which may prove more easily targeted with small molecule inhibitors. Here we show that PI3K p110α is absolutely required for pancreatic tumorigenesis while p110β is dispensable for this process. Surprisingly, ablation of p110α does not impair the ability of KRAS to activate AKT, demonstrating that AKT activation is not sufficient for transformation. Instead we find that p110α is required for robust activation of RAC1, a small GTPase required for pancreatic metaplasia. Consistent with this, our data show that p110α is necessary for regulating epithelial expression and activation of RAC-GEFs including Vav1, Tiam1 and Ect2. Ultimately, these results define the mechanistic role of p110α in pancreatic tumorigenesis and suggest selective inhibition of this PI3K isoform as a promising therapeutic approach to treating patients with pancreas cancer. Citation Format: Kenneth K. Takeuchi, Eileen Carpenter, Claire Wu, Christopher J. Halbrook, Richard Z. Lin, Howard C. Crawford. PI3K regulation of RAC1 is required for Kras-induced pancreatic tumorigenesis. [abstract]. In: Proceedings of the AACR Special Conference on Pancreatic Cancer: Innovations in Research and Treatment; May 18-21, 2014; New Orleans, LA. Philadelphia (PA): AACR; Cancer Res 2015;75(13 Suppl):Abstract nr A04.
Abstract A02: PKCι in pancreatic cancer development: A possible role for autophagy
Inman, Kristin S. , Francis, Amanda A., Murray, Nicole R.

Cancer Research | October 5, 2015 | Volume: 75 | Issue: 13_Supplement | Pages: A02-A02

10.1158/1538-7445.panca2014-a02 Get It

Abstract Pancreatic cancer is the fourth leading cause of cancer death in the United States with current 5-year survival rates at 6%. Greater than 90% of all pancreatic cancers harbor an activating mutation in codon 12 of the Kras gene (KrasG12D). Protein Kinase C iota (PKCι) has been shown to mediate KrasG12D downstream signaling and acinar-to-ductal metaplasia in an explant model of pancreatic cancer initiation. Additionally, inhibition of PKCι in human pancreatic cancer cells leads to decreased tumor size, angiogenesis, and metastasis in an orthotopic tumor model, suggesting that PKCι plays a role in maintaining the oncogenic phenotype of pancreatic cancer cells. We sought to test the hypothesis that PKCι plays a role development and maintenance of pancreatic cancer using a mouse model of KrasG12D-induced pancreatic cancer. Purpose: To identify the effect of PKCι loss on pancreas function and development of KrasG12D-induced pancreatic cancer. Procedures: Pancreata from mice with pancreas-specific deletion of PKCι, with and without pancreas-specific KrasG12D expression, were analyzed for histological and protein expression alterations. Acinar cells isolated from these transgenic mouse models were subjected to in vitro analyses to determine the role of PKCι in pancreatic cell homeostasis. Results: Mice lacking pancreatic PKCι survived and developed normally. Pancreatic knockout of PKCι expression resulted in a phenotype consistent with a defect in autophagic flux. In vitro analyses of isolated acinar cells supported the hypothesis that PKCι promotes autophagy in pancreatic cells. Autophagy exhibits a dual functionality in pancreatic cancer, acting as a tumor suppressor in normal cells and a tumor promoter in established tumor cells. We sought to determine the effect of PKCι knock-out on both of these cell types in a mouse model of pancreatic cancer. Using the LSL mouse model of K-ras induced pancreatic cancer, we demonstrated that pancreatic loss of PKCι lead to an increase in the number of Pancreatic Intraepithelial (PanIN) lesions formed in young mice. However, these lesions were protected from progressing past the early PanIN1/2 stage such that no mice lacking PKCι developed cancer, even after 1.5 years of age. By contrast, over 50% of mice with wild-type PKCι developed cancer; of those without cancer, many had progressed to the PanIN-3 stage, a stage representative of carcinoma in-situ. These data are similar to that seen in mouse models of pancreatic cancer with genetic inhibition of autophagy. Analysis of PanINs in these mice revealed that those lacking PKCι expressed significantly more P62 protein, a selective autophagy substrate, compared to PanINs with wild-type PKCι, supporting a block in the autophagic flux. These data suggest that PKCι plays an important role in both the initiation and progression of pancreatic cancer, possibly by regulating autophagic flux. Impact: Inhibition of pancreatic PKCι expression prevented progression of PanIN lesions past the early PanIN1/2 stage, resulting in a complete block in cancer development in mouse models of pancreatic cancer. Our preliminary data suggests that PKCι promotes cancer progression by regulating autophagic flux, a process that has been shown to be essential for KrasG12D-mediated pancreatic cancers. Pancreatic cancer is characterized by resistance to current therapies. Novel targets for new and more effective therapies are critical to improve outcomes for patients with this deadly disease. Inhibitors of PKCι are currently in clinical trials for ovarian and lung cancers. Our data supports the feasibility of using PKCι inhibitors for therapy in pancreatic cancer. Citation Format: Kristin S. Inman, Amanda A. Francis, Nicole R. Murray. PKCι in pancreatic cancer development: A possible role for autophagy. [abstract]. In: Proceedings of the AACR Special Conference on Pancreatic Cancer: Innovations in Research and Treatment; May 18-21, 2014; New Orleans, LA. Philadelphia (PA): AACR; Cancer Res 2015;75(13 Suppl):Abstract nr A02.
Another Report of Familial Spontaneous Coronary Artery Dissection—Reply
Goel, Kashish , Tweet, Marysia S. , Hayes, Sharonne N.

JAMA Internal Medicine | October 5, 2015 | Volume: 175 | Issue: 10 | Pages: 1721

10.1001/jamainternmed.2015.3830 | PMID 26436744 Get It

Can statistical linkage of missing variables reduce bias in treatment effect estimates in comparative effectiveness research studies?
Chang, Jessica , Olson, Melvin , Kahler, Kristijan H. , Swindle, Jason , Buzinec, Paul, Shah, N. C., Shah, Nilay , Crown, William H. , Shah, Nilay, Borah, Bijan J.

Journal of Comparative Effectiveness Research | October 5, 2015 | Volume: 4 | Issue: 5 | Pages: 455-463

10.2217/cer.15.23 | PMID 26436848 Get It

Aim: Missing data, particularly missing variables, can create serious analytic challenges in observational comparative effectiveness research studies. Statistical linkage of datasets is a potential method for incorporating missing variables. Prior studies have focused upon the bias introduced by imperfect linkage. Methods: This analysis uses a case study of hepatitis C patients to estimate the net effect of statistical linkage on bias, also accounting for the potential reduction in missing variable bias. Results: The results show that statistical linkage can reduce bias while also enabling parameter estimates to be obtained for the formerly missing variables. Conclusion: The usefulness of statistical linkage will vary depending upon the strength of the correlations of the missing variables with the treatment variable, as well as the outcome variable of interest.
Solid organ transplant in individuals with monoclonal B‐cell lymphocytosis and chronic lymphocytic leukaemia
Gharaibeh, Kamel A. , Cosio, Ferdinando G., Call, Timothy G. , Strati, Paolo , Leung, Nelson , Shanafelt, Tait D.

British Journal of Haematology | October 5, 2015 | Volume: 174 | Issue: 1 | Pages: 162-165

10.1111/bjh.13759 | PMID 26436615 Get It

Microfluidic compartments with sensing microbeads for dynamic monitoring of cytokine and exosome release from single cells
Son, Kyung Jin, Rahimian, Ali , Shin, Dong‐Sik , Siltanen, Christian , Revzin, Alexander , Patel, Tushar

The Analyst | October 5, 2015 | Volume: 141 | Issue: 2 | Pages: 679-688

10.1039/c5an01648g | PMID 26525740 Get It

Monitoring activity of single cells has high significance for basic science and diagnostic applications.
A Rare Case of Iatrogenic Deep Neck Infection Secondary to Hypopharyngeal Injury Caused by the Transesophageal Echocardiography
Choi, Jin‐Oh , Chang, Sung‐A , Kim, Sung Mok , Oh, Jae K. , Park, Seung Woo , Kim, Hyung Yoon , Lee, Sang‐Chol , Park, Sung‐Ji , Choe, Yeon Hyeon

Journal of Cardiovascular Ultrasound | October 5, 2015 | Volume: 23 | Issue: 3 | Pages: 181

10.4250/jcu.2015.23.3.181 | PMID 26448827 Get It

Management of Metastatic Apocrine Hidradenocarcinoma with Chemotherapy and Radiation
Miller, Daniel , Peterson, Jennifer , Buskirk, Steven J., Vallow, Laura A., Ta, Randy, Joseph, Richard W. , Krishna, Murli , Tzou, Katherine S., Miller, Daniel H, Peterson, Jennifer L., Joseph, Richard, Ko, Stephen J.

Rare Tumors | October 5, 2015 | Volume: 7 | Issue: 3 | Pages: 133-135

10.4081/rt.2015.6082 | PMID 26500736 Get It

Hidradenocarcinoma is a rare aggressive form of cutaneous adnexal skin carcinoma originating from the sweat gland. Due to its low incidence, prognostic and treatment strategies are still being explored both for primary and advanced disease. This tumor most often presents as either solid or cystic appearing subcutaneous nodules, which may be associated with pruritus or ulceration. To date the mainstay of treatment for local disease has been surgical excision; however, the paucity of historical data available has shown that these tumors often behave aggressively with high rates of local recurrence, metastasis, and poor overall outcomes. There are few case reports describing the utility of radiation therapy in the treatment of hidradenocarcinoma. Herein, we present a case of metastatic apocrine hidradenocarcinoma in a 32-year-old Caucasian male. The patient initially underwent excisional biopsy which confirmed the diagnosis of poorly differentiated, highly infiltrative, apocrine hidradenocarcinoma. He received systemic chemotherapy for metastatic disease, followed by radiation therapy to areas of grossly palpable adenopathy. Prior to radiation therapy the patient had an enlarged hypermetabolic conglomerate of lymph nodes in the right axilla, and borderline enlarged low activity nodes within the left axilla. He received 3 cycles of chemotherapy followed by tamoxifen and radiation therapy (50.4 Gy in 28 fractions) to areas of progressive disease in the bilateral axilla, lower neck, and axillary skin. Following treatment, the patient had complete resolution of skin nodules and improvement of his pruritus. While the role of radiation therapy in the treatment of hidradenocarcinoma has not been well established, this case report demonstrated the potential benefit of external beam radiotherapy in the management of this rare disease.